1. Home
  2. FLS vs KYMR Comparison

FLS vs KYMR Comparison

Compare FLS & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowserve Corporation

FLS

Flowserve Corporation

SELL

Current Price

$67.88

Market Cap

9.0B

Sector

Industrials

ML Signal

SELL

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$111.04

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
KYMR
Founded
1790
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.0B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
FLS
KYMR
Price
$67.88
$111.04
Analyst Decision
Buy
Strong Buy
Analyst Count
11
24
Target Price
$87.80
★ $139.35
AVG Volume (30 Days)
★ 1.4M
744.9K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
★ 1.23%
N/A
EPS Growth
★ 23.36
N/A
EPS
★ 1.41
N/A
Revenue
N/A
★ $39,211,000.00
Revenue This Year
$2.86
$167.19
Revenue Next Year
$6.96
N/A
P/E Ratio
$50.77
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$52.37
$55.66
52 Week High
$92.41
$130.05

Technical Indicators

Market Signals
Indicator
FLS
KYMR
Relative Strength Index (RSI) 35.97 51.73
Support Level $63.27 $110.64
Resistance Level $76.52 $119.89
Average True Range (ATR) 2.58 5.28
MACD -0.15 0.62
Stochastic Oscillator 17.48 74.88

Price Performance

Historical Comparison
FLS
KYMR

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: